23andMe Archives - Page 3 of 3 - Inside Precision Medicine

Inside Precision Medicine DTC-Marketed Tests Look to Clinical Studies for Growth

Color Genomics launched its $249 Color Test

News & Features

DTC-Marketed Tests Look to Clinical Studies for Growth

Alex Philippidis -

September 8, 2016

Clinical OMICs Magazine Volume 3, Issue No. 8

News & Features

Clinical OMICs Magazine Volume 3, Issue No. 8

Inside Precision Medicine Staff Writer -

August 1, 2016

Healthcare professionals express concern that due to complexities of genetic testing and counseling

Molecular Dx

Direct-to-Consumer Genetic Testing: Will It Go Away?

Patricia Fitzpatrick Dimond, Ph.D. -

September 1, 2015

Richard Scheller

News & Features

23andMe Forms Therapeutics Group Led by Genentech Veteran

Inside Precision Medicine Staff Writer -

March 13, 2015

FDA Authorizes Marketing for 23andMe Bloom Syndrome Carrier Status Test

Molecular Dx

FDA Authorizes Marketing for 23andMe Bloom Syndrome Carrier Status Test

Inside Precision Medicine Staff Writer -

February 20, 2015

1 23Page 3 of 3

Related Content

AI Identifies Autism from Basic Childhood Information

AI Identifies Autism from Basic Childhood Information

Ambry Genetics Launches New Multiomic ExomeReveal Test For Rare Disease

Ambry Genetics Launches New Multiomic ExomeReveal Test For Rare Disease

Parkinson’s Disease Genetics Analyzed in Large Study

Parkinson’s Disease Genetics Analyzed in Large Study

Study Finds Higher Rates of Hereditary Cancer Mutations in Minority Populations Missed by Current Screening Guidelines

Study Finds Higher Rates of Hereditary Cancer Mutations in Minority Populations Missed by Current Screening Guidelines